ACE2 and COVID-19: The spike protein leads to ACE2 downregulation via interaction, which contributes to the loss of ACE2-induced protective effects and stimulation of counter-regulatory angiotensin II-induced pathogenesis, promoting vasoconstriction, inflammation, and oxidative stress, thereby exacerbating COVID-19 pathogenesis [19].